RenovoRx, Inc. (RNXT): Capital Expenditures
$2.0K
Year ended 2025-12-31
$71.0K
Trailing 12 months to 2026-06-30
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.0K | -83.3% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $12.0K | n/a | 2026-03-30, From 2024-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $2.0K | -83.3% |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $7.7K | -87.8% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $185.0K | -73.2% |
| Catheter Precision, Inc. (VTAK) | 2025-12-31 | $17.0K | -74.6% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $3.68M | n/m |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2024-12-31 | $0 | -100.0% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $5.2K | -2.6% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $700.0K | -6.5% |
| Femasys Inc (FEMY) | 2025-12-31 | $525.0K | -31.1% |
Compare RNXT, PETV, SINT, VTAK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗